FDA advisers vote in favor of authorizing Novavax COVID-19 vaccine
(WASHINGTON) -- The Food and Drug Administration's independent panel of advisers has voted in favor of the FDA authorizing Novavax, a protein-based vaccine, which could soon be the fourth vaccine for COVID-19 authorized in the U.S.Although the U.S. already has three other COVID vaccines,... Read More.
